HIF1-α activates specifically pro-apoptotic genes, thus inhibiting tumor growth, while HIF2-α promotes tumor growth through the induction of pro-tumorigenic genes such as Cyclin D1 and VEGF [48]. Here, EPAS1 is linked to neoplasm.